← back to search

Diana Rofail

Regeneron (United States) · US
Area of research
Genetics · Hematology
Research interest
Research interests include Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Long-Term Effects of COVID-19, and COVID-19 Clinical Research Studies.
h-index
20
citations
3,646
works
64
NIH funding
—
primary concept
Medicine
email
diana.rofail@regeneron.com

Recent publications

Thematic analysis to explore patients’ experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives
BMJ Open 2024cited by 21position: firstdoi
Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in<i>β</i>-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial
Anemia 2012cited by 64position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mohamed Hussein · Tulane University1 papers (2024–2024)Donald K. Bowden · Monash University1 papers (2012–2012)— · 1 papers (2024–2024)Helen Lau · UNSW Sydney1 papers (2012–2012)— · 1 papers (2024–2024)Eleftherios Mylonakis · Houston Methodist1 papers (2024–2024)Arnold Ganser · Radboud University Medical Center1 papers (2012–2012)— · 1 papers (2012–2012)Yuming Zhao · Harbin Medical University1 papers (2024–2024)Dany Habr · Novartis (Switzerland)1 papers (2012–2012)Thomas Norton · Progenics Pharmaceuticals (United States)1 papers (2024–2024)Anna J. Podolanczuk · Cornell University1 papers (2024–2024)John B. Porter · University College Hospital1 papers (2012–2012)— · 1 papers (2012–2012)— · 1 papers (2024–2024)Maria Domenica Cappellini · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico1 papers (2012–2012)Selin Somersan-Karakaya · Regeneron (United States)1 papers (2024–2024)— · 1 papers (2012–2012)Marina Economou · Ippokrateio General Hospital of Thessaloniki1 papers (2012–2012)